Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.

MLA

Wang, Ying, et al. “Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.” Journal of Clinical Oncology, vol. 40, no. 20, July 2022, pp. 2246–56. EBSCOhost, https://doi.org/10.1200/JCO.21.01676.

APA

Wang, Y., Cao, J., Gu, W., Shi, M., Lan, J., Yan, Z., Jin, L., Xia, J., Ma, S., Liu, Y., Li, H., Pan, B., Chen, W., Fei, X., Wang, C., Xie, X., Yu, L., Wang, G., Li, H., & Jing, G. (2022). Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma. Journal of Clinical Oncology, 40(20), 2246–2256. https://doi.org/10.1200/JCO.21.01676

Chicago

Wang, Ying, Jiang Cao, Weiying Gu, Ming Shi, Jianping Lan, Zhiling Yan, Lai Jin, et al. 2022. “Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.” Journal of Clinical Oncology 40 (20): 2246–56. doi:10.1200/JCO.21.01676.